Therapeutic aspects of the Axl/Gas6 molecular system

被引：29
|
作者：
Di Stasi, Rossella [1 ]
De Rosa, Lucia [1 ]
D'Andrea, Luca D. [2 ]
机构：
[1] CNR, Ist Biostrutture & Bioimmagini, Via Mezzocannone 16, I-80134 Naples, Italy
[2] CNR, Ist Biostrutture & Bioimmagini, Via Nizza 52, I-10126 Turin, Italy
来源：
DRUG DISCOVERY TODAY | 2020年 / 25卷 / 12期
关键词：
RECEPTOR TYROSINE KINASE; MYELOID-LEUKEMIA CELLS; ARREST-SPECIFIC GENE-6; GROWTH-FACTOR RECEPTOR; ZIKA VIRUS-INFECTION; PROTEIN; 6; GAS6; AXL KINASE; TAM RECEPTORS; TUMOR-GROWTH; PLASMA-CONCENTRATIONS;
D O I：
10.1016/j.drudis.2020.09.022
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Axl receptor tyrosine kinase (RTK) and its ligand, growth arrest-specific protein 6 (Gas6), are involved in several biological functions and participate in the development and progression of a range of malignancies and autoimmune disorders. In this review, we present this molecular system from a drug discovery perspective, highlighting its therapeutic implications and challenges that need to be addressed. We provide an update on Axl/Gas6 axis biology, exploring its role in fields ranging from angiogenesis, cancer development and metastasis, immune response and inflammation to viral infection. Finally, we summarize the molecules that have been developed to date to target the Axl/Gas6 molecular system for and
引用
收藏
页码：2130 / 2148
页数：19
相关论文
共 50 条
  • [1] Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer
    Tanaka, Mai
    Siemann, Dietmar W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [2] Gas6/AXL pathway: immunological landscape and therapeutic potential
    Zhai, Xiaoqian
    Pu, Dan
    Wang, Rulan
    Zhang, Jiabi
    Lin, Yiyun
    Wang, Yuqing
    Zhai, Ni
    Peng, Xuan
    Zhou, Qinghua
    Li, Lu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] GAS6/AXL AXIS AS PROGNOSTIC AND THERAPEUTIC TARGET IN LIVER DISEASE
    Barcena, C.
    Stefanovic, M.
    Tutusaus, A.
    Joannas, L.
    Caballeria, J.
    Mari, M.
    Fernandez-Checa, J. C.
    Rothlin, C. V.
    Garcia de Frutos, P.
    Morales, A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S273 - S273
  • [4] The Axl/Gas6 system: Evidence for a role in neointima formation
    Melaragno, MG
    Poppa, V
    Lindner, V
    Corson, MA
    Berk, BC
    FASEB JOURNAL, 1998, 12 (04): : A105 - A105
  • [5] Overexpression of Gas6 and Axl in prostate cancer
    Stenzel, E.
    Muller, M.
    Willers, R.
    Ullrich, A.
    Gabbert, H. E.
    Engers, R.
    ONKOLOGIE, 2008, 31 : 182 - 182
  • [6] The Gas6/Axl system - A novel regulator of vascular cell function
    Melaragno, MG
    Fridell, YWC
    Berk, BC
    TRENDS IN CARDIOVASCULAR MEDICINE, 1999, 9 (08) : 250 - 253
  • [7] Coexpression of Gas6/Axl in human ovarian cancers
    Sun, WS
    Fujimoto, J
    Tamaya, T
    ONCOLOGY, 2004, 66 (06) : 450 - 457
  • [8] Gas6/Axl信号与血管新生
    雷映红
    刘承云
    杨群芳
    陈星霖
    左培缘
    医学研究杂志, 2012, 41 (11) : 7 - 9
  • [9] A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
    Tutusaus, Anna
    de Gregorio, Estefania
    Cucarull, Blanca
    Cristobal, Helena
    Areste, Cristina
    Graupera, Isabel
    Coll, Mar
    Colell, Anna
    Gausdal, Gro
    Lorens, James B.
    de Frutos, Pablo Garcia
    Morales, Albert
    Mari, Montserrat
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2020, 9 (03): : 349 - 368
  • [10] Sustained Gas6/AXL signaling network in the mes subtype of ovarian cancer as a molecular subtype specific therapeutic target.
    Huang, Ruby Yun-Ju
    Antony, Jane
    Tan, Tuan Zea
    Kelly, Zoe
    Gabra, Hani
    Recchi, Chiara
    Thiery, Jean Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345